Twin Best Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 20 Year, 8 Months
- Last Filing with ROC 31 Mar 2022
About Twin Best Pharmaceuticals
Twin Best Pharmaceuticals Private Limited (TBPPL) is a Private Limited Indian Non-Government Company incorporated in India on 07 June 2004 and has a history of 20 years and eight months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Dhrumil Parikh and Akshita Parikh serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51397MH2004PTC146787
- Company No.
146787
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Jun 2004
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Twin Best Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dhrumil Parikh  | Additional Director | 27-Jul-2022 | Current |
| Akshita Parikh | Additional Director | 27-Jul-2022 | Current |
Financial Performance of Twin Best Pharmaceuticals.
Enhance accessibility to Twin Best Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Twin Best Pharmaceuticals?
Unlock access to Twin Best Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Plumetti Fabrics Private LimitedDhrumil Parikh and Akshita Parikh are mutual person
- Spring Trade Mercantile Private Limited
Dhrumil Parikh and Akshita Parikh are mutual person
- Northstar Technologies International Limited
Dhrumil Parikh is a mutual person
- Rhut Foundation
Dhrumil Parikh is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Twin Best Pharmaceuticals?
Unlock and access historical data on people associated with Twin Best Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Twin Best Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Twin Best Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
